In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides
Identifieur interne : 004770 ( Main/Exploration ); précédent : 004769; suivant : 004771In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides
Auteurs : Xianzheng Zhou [Suède] ; Louise Berg [Suède] ; Ussama M. Abdel Motal [Suède] ; Mikael Jondal [Suède]Source :
- Journal of Immunological Methods [ 0022-1759 ] ; 1992.
Descripteurs français
- KwdFr :
- Animaux, Antigènes d'histocompatibilité de classe I (immunologie), Cytotoxicité immunologique, Données de séquences moléculaires, Femelle, Immunisation, Lymphocytes T cytotoxiques (immunologie), Peptides (immunologie), Souris, Souris de lignée C57BL, Séquence d'acides aminés, Virus de la grippe A (immunologie).
- MESH :
- Pascal (Inist)
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Cytotoxicity, Cytotoxicity, Immunologic, Female, Histocompatibility Antigens Class I (immunology), Immunization, In vivo, Induction, Influenza A virus (immunology), Influenzavirus A, Mice, Mice, Inbred C57BL, Molecular Sequence Data, Mouse, Peptides, Peptides (immunology), Synthetic product, T-Lymphocyte, T-Lymphocytes, Cytotoxic (immunology).
- MESH :
- chemical , immunology : Histocompatibility Antigens Class I, Peptides.
- immunology : Influenza A virus, T-Lymphocytes, Cytotoxic.
- Amino Acid Sequence, Animals, Cytotoxicity, Immunologic, Female, Immunization, Mice, Mice, Inbred C57BL, Molecular Sequence Data.
- Teeft :
- Cell response, Complete medium, Cytotoxic, Dynabeads system, Effeclor target ratio, Effector cells, Immune spleen cells, Immunization, Influenza, Injection site, Intravenous injection, Karolinska institute, Lmmunol, Lymphocyte, Lytic activity, Major histocompatibility, Optimal conditions, Optimal length, Peptide, Peptide vaccination, Primary cytotoxic, R6tzschke, Restimulated, Restimulation, Short peptides, Spleen, Spleen cells, Stimulator cells, Synthetic peptides, Target cells, Vaccination, Viral proteins, Virus strains, Vivo.
Abstract
Abstract: A primary cytotoxic T lymphocyte (CTL) response in vivo requires antigen presentation by cytosolic processing and can not in general be obtained by vaccination with soluble proteins. In the present work we have found that vaccination of mice with pre-processed synthetic peptides, corresponding to endogenous 9-mers produced in influenza A virus-infected cells, resulted in strong primary CTL responses. The generated CTL efficiently killed virus-infected target cells with preference for viral strains having the identical amino acid sequences to the peptides used for immunization. The optimal conditions for a primary in vivo CTL response was obtained with 100 μg peptide dissolved in incomplete Freund's adjuvant and injected s.c. at the base of tail. Spleen cells which had been primed 7–10 days earlier were restimulated for 5 days in vitro, using an optimal low peptide concentration (0.05 μM) and tested against virus-infected and peptide-treated target cells. The peptide-induced CTL were major histocompatibility complex class I restricted and CD8 positive.
Url:
DOI: 10.1016/0022-1759(92)90322-K
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000513
- to stream Istex, to step Curation: 000513
- to stream Istex, to step Checkpoint: 001D52
- to stream Main, to step Merge: 004842
- to stream PascalFrancis, to step Corpus: 000111
- to stream PascalFrancis, to step Curation: 000103
- to stream PascalFrancis, to step Checkpoint: 000110
- to stream Main, to step Merge: 004921
- to stream PubMed, to step Corpus: 002949
- to stream PubMed, to step Curation: 002949
- to stream PubMed, to step Checkpoint: 002806
- to stream Ncbi, to step Merge: 000283
- to stream Ncbi, to step Curation: 000283
- to stream Ncbi, to step Checkpoint: 000283
- to stream Main, to step Merge: 004796
- to stream Main, to step Curation: 004770
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides</title>
<author><name sortKey="Zhou, Xianzheng" sort="Zhou, Xianzheng" uniqKey="Zhou X" first="Xianzheng" last="Zhou">Xianzheng Zhou</name>
</author>
<author><name sortKey="Berg, Louise" sort="Berg, Louise" uniqKey="Berg L" first="Louise" last="Berg">Louise Berg</name>
</author>
<author><name sortKey="Abdel Motal, Ussama M" sort="Abdel Motal, Ussama M" uniqKey="Abdel Motal U" first="Ussama M." last="Abdel Motal">Ussama M. Abdel Motal</name>
</author>
<author><name sortKey="Jondal, Mikael" sort="Jondal, Mikael" uniqKey="Jondal M" first="Mikael" last="Jondal">Mikael Jondal</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7C9B485472D1654106BEE83E0785B006A8CBE96E</idno>
<date when="1992" year="1992">1992</date>
<idno type="doi">10.1016/0022-1759(92)90322-K</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-RDC9V5JS-Z/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000513</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000513</idno>
<idno type="wicri:Area/Istex/Curation">000513</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D52</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D52</idno>
<idno type="wicri:doubleKey">0022-1759:1992:Zhou X:in:vivo:primary</idno>
<idno type="wicri:Area/Main/Merge">004842</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:93-0035362</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000111</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000103</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000110</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000110</idno>
<idno type="wicri:doubleKey">0022-1759:1992:Zhou X:in:vivo:primary</idno>
<idno type="wicri:Area/Main/Merge">004921</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:1517589</idno>
<idno type="wicri:Area/PubMed/Corpus">002949</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002949</idno>
<idno type="wicri:Area/PubMed/Curation">002949</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002949</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002806</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002806</idno>
<idno type="wicri:Area/Ncbi/Merge">000283</idno>
<idno type="wicri:Area/Ncbi/Curation">000283</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000283</idno>
<idno type="wicri:doubleKey">0022-1759:1992:Zhou X:in:vivo:primary</idno>
<idno type="wicri:Area/Main/Merge">004796</idno>
<idno type="wicri:Area/Main/Curation">004770</idno>
<idno type="wicri:Area/Main/Exploration">004770</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides</title>
<author><name sortKey="Zhou, Xianzheng" sort="Zhou, Xianzheng" uniqKey="Zhou X" first="Xianzheng" last="Zhou">Xianzheng Zhou</name>
<affiliation wicri:level="1"><country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Immunology, Karolinska Institute, Box 60400, 104 01 Stockholm</wicri:regionArea>
<wicri:noRegion>104 01 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Berg, Louise" sort="Berg, Louise" uniqKey="Berg L" first="Louise" last="Berg">Louise Berg</name>
<affiliation wicri:level="1"><country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Immunology, Karolinska Institute, Box 60400, 104 01 Stockholm</wicri:regionArea>
<wicri:noRegion>104 01 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abdel Motal, Ussama M" sort="Abdel Motal, Ussama M" uniqKey="Abdel Motal U" first="Ussama M." last="Abdel Motal">Ussama M. Abdel Motal</name>
<affiliation wicri:level="1"><country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Immunology, Karolinska Institute, Box 60400, 104 01 Stockholm</wicri:regionArea>
<wicri:noRegion>104 01 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jondal, Mikael" sort="Jondal, Mikael" uniqKey="Jondal M" first="Mikael" last="Jondal">Mikael Jondal</name>
<affiliation wicri:level="1"><country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Immunology, Karolinska Institute, Box 60400, 104 01 Stockholm</wicri:regionArea>
<wicri:noRegion>104 01 Stockholm</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Immunological Methods</title>
<title level="j" type="abbrev">JIM</title>
<idno type="ISSN">0022-1759</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1992">1992</date>
<biblScope unit="volume">153</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="193">193</biblScope>
<biblScope unit="page" to="200">200</biblScope>
</imprint>
<idno type="ISSN">0022-1759</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-1759</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cytotoxicity</term>
<term>Cytotoxicity, Immunologic</term>
<term>Female</term>
<term>Histocompatibility Antigens Class I (immunology)</term>
<term>Immunization</term>
<term>In vivo</term>
<term>Induction</term>
<term>Influenza A virus (immunology)</term>
<term>Influenzavirus A</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Molecular Sequence Data</term>
<term>Mouse</term>
<term>Peptides</term>
<term>Peptides (immunology)</term>
<term>Synthetic product</term>
<term>T-Lymphocyte</term>
<term>T-Lymphocytes, Cytotoxic (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antigènes d'histocompatibilité de classe I (immunologie)</term>
<term>Cytotoxicité immunologique</term>
<term>Données de séquences moléculaires</term>
<term>Femelle</term>
<term>Immunisation</term>
<term>Lymphocytes T cytotoxiques (immunologie)</term>
<term>Peptides (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Séquence d'acides aminés</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Histocompatibility Antigens Class I</term>
<term>Peptides</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Antigènes d'histocompatibilité de classe I</term>
<term>Lymphocytes T cytotoxiques</term>
<term>Peptides</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
<term>T-Lymphocytes, Cytotoxic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cytotoxicity, Immunologic</term>
<term>Female</term>
<term>Immunization</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Molecular Sequence Data</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Animaux</term>
<term>Cytotoxicité</term>
<term>Cytotoxicité immunologique</term>
<term>Données de séquences moléculaires</term>
<term>Femelle</term>
<term>Immunisation</term>
<term>In vivo</term>
<term>Induction</term>
<term>Influenzavirus A</term>
<term>Lymphocyte T</term>
<term>Peptide</term>
<term>Produit synthétique</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Séquence d'acides aminés</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Cell response</term>
<term>Complete medium</term>
<term>Cytotoxic</term>
<term>Dynabeads system</term>
<term>Effeclor target ratio</term>
<term>Effector cells</term>
<term>Immune spleen cells</term>
<term>Immunization</term>
<term>Influenza</term>
<term>Injection site</term>
<term>Intravenous injection</term>
<term>Karolinska institute</term>
<term>Lmmunol</term>
<term>Lymphocyte</term>
<term>Lytic activity</term>
<term>Major histocompatibility</term>
<term>Optimal conditions</term>
<term>Optimal length</term>
<term>Peptide</term>
<term>Peptide vaccination</term>
<term>Primary cytotoxic</term>
<term>R6tzschke</term>
<term>Restimulated</term>
<term>Restimulation</term>
<term>Short peptides</term>
<term>Spleen</term>
<term>Spleen cells</term>
<term>Stimulator cells</term>
<term>Synthetic peptides</term>
<term>Target cells</term>
<term>Vaccination</term>
<term>Viral proteins</term>
<term>Virus strains</term>
<term>Vivo</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: A primary cytotoxic T lymphocyte (CTL) response in vivo requires antigen presentation by cytosolic processing and can not in general be obtained by vaccination with soluble proteins. In the present work we have found that vaccination of mice with pre-processed synthetic peptides, corresponding to endogenous 9-mers produced in influenza A virus-infected cells, resulted in strong primary CTL responses. The generated CTL efficiently killed virus-infected target cells with preference for viral strains having the identical amino acid sequences to the peptides used for immunization. The optimal conditions for a primary in vivo CTL response was obtained with 100 μg peptide dissolved in incomplete Freund's adjuvant and injected s.c. at the base of tail. Spleen cells which had been primed 7–10 days earlier were restimulated for 5 days in vitro, using an optimal low peptide concentration (0.05 μM) and tested against virus-infected and peptide-treated target cells. The peptide-induced CTL were major histocompatibility complex class I restricted and CD8 positive.</div>
</front>
</TEI>
<affiliations><list><country><li>Suède</li>
</country>
</list>
<tree><country name="Suède"><noRegion><name sortKey="Zhou, Xianzheng" sort="Zhou, Xianzheng" uniqKey="Zhou X" first="Xianzheng" last="Zhou">Xianzheng Zhou</name>
</noRegion>
<name sortKey="Abdel Motal, Ussama M" sort="Abdel Motal, Ussama M" uniqKey="Abdel Motal U" first="Ussama M." last="Abdel Motal">Ussama M. Abdel Motal</name>
<name sortKey="Berg, Louise" sort="Berg, Louise" uniqKey="Berg L" first="Louise" last="Berg">Louise Berg</name>
<name sortKey="Jondal, Mikael" sort="Jondal, Mikael" uniqKey="Jondal M" first="Mikael" last="Jondal">Mikael Jondal</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004770 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004770 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:7C9B485472D1654106BEE83E0785B006A8CBE96E |texte= In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides }}
This area was generated with Dilib version V0.6.33. |